Average Co-Inventor Count = 4.83
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Corporation (50 from 1,829 patents)
2. Merck Sharp + Dohme Corp. (4 from 2,405 patents)
3. Other (3 from 832,680 patents)
4. Hoffmann-la Roche Inc. (1 from 4,942 patents)
5. Schering-plough Corporation (1 from 28 patents)
6. Pharacopeia Drug Discovery, Inc. (1 from 1 patent)
59 patents:
1. 9278965 - Bridged and fused antidiabetic compounds
2. 8759337 - Gamma secretase modulators
3. 8664411 - Tetrahydropyranochromene gamma secretase inhibitors
4. 8569521 - Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
5. 8450343 - Gamma secretase modulators
6. 8426403 - Gamma secretase modulators
7. 8357682 - Gamma secretase modulators
8. 8114879 - Piperazine derivatives useful as CCR5 antagonists
9. 8067621 - Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
10. 7998958 - Substituted N-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
11. RE42461 - Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
12. 7741289 - Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
13. 7732413 - Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
14. 7459442 - Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
15. 7452891 - MCH antagonists and their use in the treatment of obesity